Multi Sites Urine Drug Testing

Added: Oct 24, 2016 2:44 pm  

SOLICITATION NO. VA242-17-Q-0040

 

Purpose: The purpose of this synopsis is to provide a notice to the public of information applicable to the BPA Urine Drug Testing Services for the Veterans Administration, James J. Peters VA Medical Center (VAMC).



Authority: Network Contracting Office 2 (NCO 2) is issuing this synopsis in accordance with FAR Part 5.204 Pre-solicitation Notices.



Description:









The Network Contracting Office 2 (NCO 2), has a need for five (5) years BPA Urine Drug Testing Services beginning in December 1, 2016 with For this requirement, Urine Drug Testing Services include, but are not limited to:

The contractor shall provide referral laboratory services to include:



Utilizing a single patient sample, perform quantitative testing using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) methodology of medications typical for pain and substance abuse, as well as adjunct new generation medications (Selective serotonin reuptake inhibitors (SSRI s)) and emerging recreational drugs (bath salts, spice compounds) without the use of an immune assay screening methodology.



Testing to include, but not limited to, common drugs in the following classes: Natural, semi-synthetic and synthetic opioids; Benzodiazepines; tricyclic antidepressants; serotonin uptake inhibitors; stimulants; barbiturates; illicit drugs and their metabolites.



Testing is to be completed by LC-MS/MS methodology only, without the use of Immuno-assay screening tests.



All supplies necessary for collection of patient urine specimens

Specimen containers

b) Required requisition forms

c) Biohazard bags, preservatives, and absorbent sheets



All supplies needed to transport samples from the sites to the testing facility: United Parcel Service (UPS)/mailing bags, request forms, and pre-paid shipping labels.

Pre-analytic processing, analysis and reporting of analytic results



Specimen preparation and storage; transportation of clinical laboratory specimens, microbiology cultures, and stocks; performance of analytical testing; reporting of analytical test results; and consultative services.













Place of Performance:



James J. Peters VA Medical Center

130 West Kingsbridge Rd

Bronx, NY 10468-3904



VA New York Harbor Healthcare System

800 Poly Place

Brooklyn, NY 11209-7104



VA New Jersey Healthcare System

385 Tremont Avenue

East Orange, NJ 07018-1023



VA New York Harbor Healthcare System

423 East 23ed ST

New York, NY 10010-5011





VA Medical Center

79 Middleville Road

Northport, NY 11768-2200



VA Hudson Valley Healthcare System

2094 Albany Post Rd

Montrose, NY 10548-1454



VA Hudson Valley HealthCare System

41 Castle Point Rd

Wappingers Falls, NY 12590



VA New Jersey Healthcare System

151 Knollcroft Rd

Lyons, NJ 07939-5001





Sole Source/Competitive Acquisition: This will be a competitive acquisition set-aside for small business participation under NAICS code 621511.



BPA Type: Firm Fixed-Price



Period of Performance:  Total BPA period of performance of 5 years.



Government-Furnished Property/Equipment: None

Expiration of this synopsis/notice: November 4, 2016.



Release Date of the Solicitation: It is anticipated that Solicitation No. VA242-17-Q-0040will be released in November 7, 2017. Should complications arise resulting in a delay in the release of the solicitation; the Contracting Officer will provide an update through FBO.